January 4, 2023

Pharmaceutical Company to Produce Affordable Insulin in Petersburg

January 24, 2023

AmerisourceBergen Kicks Off Strategic Relationship with Civica

AmerisourceBergen will serve as Civica, Inc.’s exclusive distribution partner, providing supply chain support for Civica’s products and working to ensure that Civica’s crucial products reach its members across the country efficiently, reliably and securely. The partnership aims to accelerate mutual efforts to ensure the stability of supply of essential generic medicines nationwide.

Media Coverage

AmerisourceBergen Kicks Off Strategic Relationship with Civica
AmerisourceBergen Kicks Off Strategic Relationship with Civica

January 31, 2023

Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative

“As a renowned injection device specialist with over 35 years’ experience, Ypsomed will help Civica make self-administered care more affordable for Americans living with diabetes,” said Ned McCoy, President and Chief Executive Officer of Civica. “Civica will deliver affordable, high-quality insulin, in the best pen platform, utilizing our new, state of the art manufacturing technology in Petersburg, Virginia.”

Media Coverage

Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative
Civica Partners with Ypsomed for Insulin Injection Pen

February 8, 2023

Utah-based Nonprofit Set to Open $140M Insulin Plant in Petersburg

Petersburg is at the center of a nonprofit’s push to lower sky-high insulin costs. Utah-based Civica Rx is in the final stages of building a $140 million insulin production plant in the city and expects to begin retail sales in 2024.

Media Coverage

Utah-based Nonprofit Set to Open $140M Insulin Plant in Petersburg
Game-changing Moves in Petersburg to Produce Affordable Insulin (Please advance video to 12:00)

March 18, 2023

California Selects Civica Rx as Its Insulin Manufacturing Partner

California’s partnership with Civica is a game changer,” said California Governor Gavin Newsom, announcing the state’s choice of Civica to manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative. “We are proud to be working with Civica to bring true price competition into the insulin drug market and ease the financial burden for Californians living with diabetes.”

(Please advance video to 22:00)

Media Coverage

California Selects Civica Rx as Its Insulin Manufacturing Partner
Governor Newsom Announces $30 Insulin Through CalRx
California Enters a Contract to Make Its Own Affordable Insulin
California Invests $50M to Partner with Civica Rx on Insulin Manufacturing

April 11, 2023

CivicaScript, SortPak Partner to Package & Deliver Medicines to Maximize Patient Convenience, Compliance & Savings

CivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and SortPak, which delivers pre-sorted medications to patients at no extra cost to patients or health plans, are partnering to provide CivicaScript medicines in packaging designed to maximize patient convenience, savings and medication compliance.

Media Coverage

CivicaScript, SortPak Partner to Package & Deliver Medicines to Maximize Patient Convenience, Compliance & Savings
CivicaScript, SortPak Partner to Package & Deliver Medicines

April 20, 2023

What Spurred Lilly, Novo and Sanofi to Slash Insulin Prices? Expert Gives Her Take

The price cuts can be explained by a mix of factors, Leemore Dafny, Ph.D., wrote in a new analysis for The New England Journal of Medicine, titled “Falling Insulin Prices – What Just Happened?” One: The market is awaiting the entry of certain manufacturers that “don’t benefit from high prices.” Two: Government regulations are making it “costlier” for insulin manufacturers to keep charging their prior prices. Three: Public shaming.

Media Coverage

What Spurred Lilly, Novo and Sanofi to Slash Insulin Prices? Expert Gives Her Take
Falling Insulin Prices – What Just Happened?

May 3, 2023

CivicaRx Disrupts Out of Control Prescription Medication Pricing

Civica believes its model of rallying others to work together to ensure a reliable supply of fairly priced medicines is one that the wider pharmaceutical industry can ultimately support.

Media Coverage

CivicaRx Disrupts Out of Control Prescription Medication Pricing Through Market Solutions Rather Than Government Regulation
u003cnav class=u0022section-navu0022u003en u003cul class=u0022menuu0022 id=u0022main-menuu0022u003enu003cli style=u0022padding-bottom: 10px;u0022u003eu003cselect id=u0022mySelect18u0022 name=u0022formau0022 class=u0022select2018u0022 onchange=u0022location = this.value, jsFunction18();u0022u003en u003coption value=u0022u0022 selectedu003e u003c/optionu003entttu003coption value=u0022/timeline-2018/#jan-1u0022u003e1.18u003c/optionu003entttu003coption value=u0022/timeline-2018/#sept-1u0022u003e9.06u003c/optionu003entttu003coption value=u0022/timeline-2018/#sept-novu0022u003e9–12u003c/optionu003enu003c/selectu003enttttu003cscriptu003entttfunction jsFunction18()n{ntdocument.getElementById(u0022mySelect18u0022).selectedIndex = u00220u0022;n}u003c/scriptu003ennu003c/liu003enttntntu003cli style=u0022padding-bottom: 10px;u0022u003eu003cselect id=u0022mySelect19u0022 class=u0022select2019u0022 name=u0022formau0022 onchange=u0022location = this.value, jsFunction19();u0022u003en u003coption value=u0022u0022 selectedu003e u003c/optionu003entttu003coption value=u0022/timeline-2019/#jan-2019u0022u003e1.07u003c/optionu003entttu003coption value=u0022/timeline-2019/#apr-2019u0022u003e4.18u003c/optionu003entttu003coption value=u0022/timeline-2019/#may-2019u0022u003e5.15u003c/optionu003entttu003coption value=u0022/timeline-2019/#jun-2019u0022u003e6.17u003c/optionu003entttu003coption value=u0022/timeline-2019/#jun2-2019u0022u003e6.20u003c/optionu003entttu003coption value=u0022/timeline-2019/#july-2019u0022u003e7.23u003c/optionu003entttu003coption value=u0022/timeline-2019/#aug-2019u0022u003e8.01u003c/optionu003entttu003coption value=u0022/timeline-2019/#sept-2019u0022u003e9.10u003c/optionu003entt u003coption value=u0022/timeline-2019/#oct-2019u0022u003e10.02u003c/optionu003entu003coption value=u0022/timeline-2019/#dec-2019u0022u003e12.10u003c/optionu003entttu003c/selectu003entttttu003cscriptu003entttfunction jsFunction19()n{ntdocument.getElementById(u0022mySelect19u0022).selectedIndex = u00220u0022;n}u003c/scriptu003enu003c/liu003entttnttu003cliu003en u003cselect id=u0022mySelectu0022 name=u0022formau0022 onchange=u0022location = this.value, jsFunction();u0022u003en u003coption value=u0022u0022 selectedu003e u003c/optionu003entttu003coption value=u0022/timeline-2020/#jan-2020u0022u003e1.16u003c/optionu003entttu003coption value=u0022/timeline-2020/#jan2-2020u0022u003e1.23u003c/optionu003entttu003coption value=u0022/timeline-2020/#apr-2020u0022u003e3-4u003c/optionu003entttu003coption value=u0022/timeline-2020/#apr-2020Bu0022u003e3-4u003c/optionu003entttu003coption value=u0022/timeline-2020/#may-2020u0022u003e5.01u003c/optionu003entttu003coption value=u0022/timeline-2020/#may2-2020u0022u003e5.19u003c/optionu003entttu003coption value=u0022/timeline-2020/#may-jun-2020u0022u003e5-6u003c/optionu003entttu003coption value=u0022/timeline-2020/#june-2020u0022u003e6.02u003c/optionu003entttu003coption value=u0022/timeline-2020/#june2-2020u0022u003e6.18u003c/optionu003en u003coption value=u0022/timeline-2020/#jul-2020u0022u003e7.07u003c/optionu003en u003coption value=u0022/timeline-2020/#sept-2020u0022u003e9.06u003c/optionu003enn u003coption value=u0022/timeline-2020/#sept-2020-21u0022u003e9.21u003c/optionu003en u003coption value=u0022/timeline-2020/#sept-2020-26u0022u003e9.26u003c/optionu003en u003coption value=u0022/timeline-2020/#oct-2020-05u0022u003e10.05u003c/optionu003en u003coption value=u0022/timeline-2020/#oct-2020-21u0022u003e10.21u003c/optionu003en u003coption value=u0022/timeline-2020/#nov-2020-12u0022u003e11.12u003c/optionu003en u003c/selectu003entttu003cscriptu003entttfunction jsFunction()n{ntdocument.getElementById(u0022mySelectu0022).selectedIndex = u00220u0022;n}u003c/scriptu003entn u003c/liu003entttttttntttu003cli u003eu003cselect id=u0022mySelect21u0022 name=u0022formau0022 class=u0022select2021u0022 onchange=u0022location = this.value, jsFunction21();u0022u003en u003coption value=u0022u0022 selectedu003e u003c/optionu003etntttu003coption value=u0022/timeline-2021/#jan-21u0022u003e1.21u003c/optionu003entttu003coption value=u0022/timeline-2021/#jan-29u0022u003e1.29u003c/optionu003entttu003coption value=u0022/timeline-2021/#feb-maru0022u003e2–3u003c/optionu003enttttu003coption value=u0022/timeline-2021/#may-01u0022u003e5.01u003c/optionu003entttttu003coption value=u0022/timeline-2021/#may-04u0022u003e5.04u003c/optionu003enttttu003coption value=u0022/timeline-2021/#june-01u0022u003e6.01u003c/optionu003enttttu003coption value=u0022/timeline-2021/#june-16u0022u003e6.16u003c/optionu003enttttu003coption value=u0022/timeline-2021/#july-08u0022u003e7.08u003c/optionu003enttttu003coption value=u0022/timeline-2021/#aug-10u0022u003e8.10u003c/optionu003enttttu003coption value=u0022/timeline-2021/#sep-06u0022u003e9.06u003c/optionu003enttttu003coption value=u0022/timeline-2021/#sep-19u0022u003e9.19u003c/optionu003enttttu003coption value=u0022/timeline-2021/#nov-10u0022u003e11.10u003c/optionu003enttttu003coption value=u0022/timeline-2021/#dec-07u0022u003e12.07u003c/optionu003enttttnttttnnu003c/selectu003enttttu003cscriptu003entttfunction jsFunction21()n{ntdocument.getElementById(u0022mySelect21u0022).selectedIndex = u00220u0022;n}u003c/scriptu003ennu003c/liu003entttntttttnttttttu003cliu003eu003cselect id=u0022mySelect22u0022 name=u0022formau0022 class=u0022select2022u0022 onchange=u0022location = this.value, jsFunction22();u0022u003en u003coption value=u0022u0022 selectedu003e u003c/optionu003entttu003coption value=u0022/timeline-2022/#jan-22u0022u003e1.01u003c/optionu003entttu003coption value=u0022/timeline-2022/#mar-01u0022u003e3.01u003c/optionu003entttu003coption value=u0022/timeline-2022/#mar-24u0022u003e3.24u003c/optionu003enttttu003coption value=u0022/timeline-2022/#apr-01u0022u003e4.01u003c/optionu003entttttu003coption value=u0022/timeline-2022/#apr-02u0022u003e4.01u003c/optionu003enttttu003coption value=u0022/timeline-2022/#apr-06u0022u003e4.06u003c/optionu003en u003coption value=u0022/timeline-2022/#apr-26u0022u003e4.26u003c/optionu003enttttu003coption value=u0022/timeline-2022/#may-04u0022u003e5.04u003c/optionu003enttttu003coption value=u0022/timeline-2022/#may-24u0022u003e5.24u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jun-01u0022u003e6.01u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jun-02u0022u003e6.02u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jun-14u0022u003e6.14u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jun-15u0022u003e6.15u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jun-30u0022u003e6.30u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jul-13u0022u003e7.01u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jul-13Au0022u003e7.13u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jul-21u0022u003e7.21u003c/optionu003enttttu003coption value=u0022/timeline-2022/#jul-25u0022u003e7.25u003c/optionu003enttttu003coption value=u0022/timeline-2022/#aug-03u0022u003e8.03u003c/optionu003enttttu003coption value=u0022/timeline-2022/#sep-06u0022u003e9.06u003c/optionu003enttttu003coption value=u0022/timeline-2022/#sep-08u0022u003e9.08u003c/optionu003enttttu003coption value=u0022/timeline-2022/#sep-09u0022u003e9.09u003c/optionu003enttttu003coption value=u0022/timeline-2022/#sep-12u0022u003e9.12u003c/optionu003enttttu003coption value=u0022/timeline-2022/#oct-01u0022u003e10.01u003c/optionu003enttttu003coption value=u0022/timeline-2022/#nov-dec-2022u0022u003e11-12u003c/optionu003ennu003c/selectu003enttttu003cscriptu003entttfunction jsFunction22()n{ntdocument.getElementById(u0022mySelect22u0022).selectedIndex = u00220u0022;n}u003c/scriptu003ennu003c/liu003enttntttu003cliu003eu003cselect id=u0022mySelect23u0022 name=u0022formau0022 class=u0022select2023u0022 onchange=u0022location = this.value, jsFunction22();u0022u003en u003coption value=u0022u0022 selectedu003e u003c/optionu003entttu003coption value=u0022#jan-04u0022u003e1.04u003c/optionu003entttu003coption value=u0022#jan-24u0022u003e1.24u003c/optionu003entttu003coption value=u0022#jan-31u0022u003e1.31u003c/optionu003enttttu003coption value=u0022#feb-08u0022u003e2.08u003c/optionu003entttttu003coption value=u0022#mar-18u0022u003e3.18u003c/optionu003ennttttu003coption value=u0022#apr-11u0022u003e4.11u003c/optionu003enttttttttu003coption value=u0022#apr-20u0022u003e4.20u003c/optionu003enttttttttttttu003coption value=u0022#may-03u0022u003e5.03u003c/optionu003ennu003c/selectu003enttttu003cscriptu003entttfunction jsFunction22()n{ntdocument.getElementById(u0022mySelect23u0022).selectedIndex = u00220u0022;n}u003c/scriptu003ennu003c/liu003entttttntttttntttttntttttntttttntttttntttttntttttn u003c/ulu003enu003c/navu003en
u003csection class=u0022scrollspyu0022 u003entttu003cp id=u0022jan-04u0022 class=u0022monthsu0022u003eJanuary 4, 2023u003c/pu003enu003c/sectionu003en

u003ch1u003ePharmaceutical Company to Produce Affordable Insulin in Petersburgu003c/h1u003e

ttu003csection class=u0022scrollspyu0022 u003entttu003cp id=u0022jan-24u0022 class=u0022monthsu0022u003eJanuary 24, 2023u003c/pu003enttu003c/sectionu003en

u003ch1u003eAmerisourceBergen Kicks Off Strategic Relationship with Civicau003c/h1u003enu003cp class=u0022body-contentu0022u003enAmerisourceBergen will serve as Civica, Inc.’s exclusive distribution partner, providing supply chain support for Civica’s products and working to ensure that Civica’s crucial products reach its members across the country efficiently, reliably and securely. The partnership aims to accelerate mutual efforts to ensure the stability of supply of essential generic medicines nationwide.u003c/pu003ennn

u003ch4u003eMedia Coverageu003c/h4u003e

u003culu003enu003ca href=u0022https://civicarx.org/wp-content/uploads/2023/01/Civica-AB-Partnership-Release_1.20.23.pdfu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eCivica Press Releaseu003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eAmerisourceBergen Kicks Off Strategic Relationship with Civicau003c/divu003enn

u003culu003enu003ca href=u0022https://www.biospace.com/article/releases/amerisourcebergen-kicks-off-strategic-relationship-with-civica/u0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eBiospaceu003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eAmerisourceBergen Kicks Off Strategic Relationship with Civicau003c/divu003e

ttu003csection class=u0022scrollspyu0022 id=u0022jan-31u0022u003entttu003cp class=u0022monthsu0022u003eJanuary 31, 2023u003c/pu003enttu003c/sectionu003e

u003ch1u003eCivica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiativeu003c/h1u003ennu003cp class=u0022body-contentu0022u003eu0022As a renowned injection device specialist with over 35 years’ experience, Ypsomed will help Civica make self-administered care more affordable for Americans living with diabetes,” said Ned McCoy, President and Chief Executive Officer of Civica. “Civica will deliver affordable, high-quality insulin, in the best pen platform, utilizing our new, state of the art manufacturing technology in Petersburg, Virginia.u0022nu003c!u002du002du003cdiv class=u0022timeline-caption font-greenu0022 style=u0022padding-top: 10px;u0022u003e– Dan Liljenquist, u003cbr /u003eBoard Chair of Civica, and Chief Strategy Officer, u003cbr /u003eIntermountain Healthcare, and Martin VanTrieste, Civica CEO nu003c/divu003eu002du002du003eu003c/pu003e

u003ch4u003eMedia Coverageu003c/h4u003e

u003culu003enu003ca href=u0022https://civicarx.org/wp-content/uploads/2023/01/Ypsomed-Partnership-for-31-January-2023-FINAL.pdfu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eCivica Press Releaseu003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eCivica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiativeu003c/divu003enn

u003culu003enu003ca href=u0022https://www.contractpharma.com/contents/view_breaking-news/2023-02-07/civica-partners-with-ypsomed-for-insulin-injection-pen/u0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eContract Pharmau003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eCivica Partners with Ypsomed for Insulin Injection Pennu003c/divu003e

ttu003csection class=u0022scrollspyu0022 id=u0022feb-08u0022u003entttu003cp class=u0022monthsu0022u003eFebruary 8, 2023u003c/pu003enttu003c/sectionu003e

u003ch1u003eUtah-based Nonprofit Set to Open $140M Insulin Plant in Petersburgu003c/h1u003enu003cp class=u0022body-contentu0022u003ePetersburg is at the center of a nonprofit’s push to lower sky-high insulin costs. Utah-based Civica Rx is in the final stages of building a $140 million insulin production plant in the city and expects to begin retail sales in 2024. u003c/pu003enn

u003ch4u003eMedia Coverageu003c/h4u003e

u003culu003enu003ca href=u0022https://www.axios.com/local/richmond/2023/02/08/petersburg-insulin-plant-nonprofit-pricesu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eAxios u003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eUtah-based Nonprofit Set to Open $140M Insulin Plant in Petersburgu003c/divu003enn

u003culu003enu003ca href=u0022https://www.youtube.com/watch?v=vaYGs1ZdIvsu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eVirtual Innovation Spotlight Webinar u003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eGame-changing Moves in Petersburg to Produce Affordable Insulin u003ciu003e(Please advance video to 12:00)u003c/iu003eu003c/divu003enn

ttu003csection class=u0022scrollspyu0022 id=u0022mar-18u0022u003entttu003cp class=u0022months anchoru0022u003eMarch 18, 2023u003c/pu003enttu003c/sectionu003e

u003ch1u003eCalifornia Selects Civica Rx as Its Insulin Manufacturing Partneru003c/h1u003ennu003cp class=u0022body-contentu0022u003eCalifornia’s partnership with Civica is a game changer,” said California Governor Gavin Newsom, announcing the state’s choice of Civica to manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative. “We are proud to be working with Civica to bring true price competition into the insulin drug market and ease the financial burden for Californians living with diabetes.u0022nu003c/pu003en

u003cem style=u0022font-size: 14px;u0022u003e(Please advance video to 22:00)u003c/emu003e

u003ch4u003eMedia Coverageu003c/h4u003e

u003culu003enu003ca href=u0022https://www.civicainsulin.org/wp-content/uploads/2023/03/Civica-and-California-Partnership-PR-FINAL_.pdfu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eCivica Press Releaseu003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eCalifornia Selects Civica Rx as Its Insulin Manufacturing Partneru003c/divu003enn

u003culu003enu003ca href=u0022https://www.gov.ca.gov/2023/03/18/governor-newsom-announces-30-insulin-through-calrx/u0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eOffice of California Governor Gavin Newsomu003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eGovernor Newsom Announces $30 Insulin Through CalRxu003c/divu003e

u003culu003enu003ca href=u0022https://www.wbur.org/npr/1164572757/california-contract-cheap-insulin-calrxu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eu003cliu003eWBURu003c/liu003eu003c/au003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eCalifornia Enters a Contract to Make Its Own Affordable Insulinu003c/divu003e

nu003culu003en tu003cliu003eu003ca href=u0022https://www.fiercepharma.com/manufacturing/california-invests-50m-partner-civica-rx-insulin-manufacturingu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eFierce Pharmau003c/au003eu003c/liu003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eCalifornia Invests $50M to Partner with Civica Rx on Insulin Manufacturingu003c/divu003en

ttu003csection class=u0022scrollspyu0022 id=u0022apr-11u0022u003entttu003cp class=u0022monthsu0022u003eApril 11, 2023u003c/pu003enttu003c/sectionu003e

u003ch1u003eCivicaScript, SortPak Partner to Package u0026 Deliver Medicines to Maximize Patient Convenience, Compliance u0026 Savingsu003c/h1u003enu003cp class=u0022body-contentu0022u003eCivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and SortPak, which delivers pre-sorted medications to patients at no extra cost to patients or health plans, are partnering to provide CivicaScript medicines in packaging designed to maximize patient convenience, savings and medication compliance.u003c/pu003en

u003ch4u003eMedia Coverageu003c/h4u003e

nu003culu003en tu003cliu003eu003ca href=u0022https://civicarx.org/wp-content/uploads/2023/04/CivicaScript-SortPak-Final.pdfu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eCivica Press Releaseu003c/au003eu003c/liu003enu003c/ulu003ennu003cdiv class=u0022timeline-media-titleu0022u003eCivicaScript, SortPak Partner to Package u0026 Deliver Medicines to Maximize Patient Convenience, Compliance u0026 Savingsu003c/divu003e

u003culu003en tu003cliu003eu003ca href=u0022https://www.packagingconnections.com/news/civicascripttm-sortpak-partner-package-deliver-medicines-maximize-patient-convenienceu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003ePackaging Connectionsu003c/au003eu003c/liu003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eCivicaScript, SortPak Partner to Package u0026 Deliver Medicinesu003c/divu003e

ttu003csection class=u0022scrollspyu0022 id=u0022apr-20u0022u003entttu003cp class=u0022monthsu0022u003eApril 20, 2023u003c/pu003enttu003c/sectionu003e

u003ch1u003eWhat Spurred Lilly, Novo and Sanofi to Slash Insulin Prices? Expert Gives Her Takeu003c/h1u003ennu003cp class=u0022body-contentu0022u003eThe price cuts can be explained by a mix of factors, Leemore Dafny, Ph.D., wrote in a new analysis for u003ciu003eThe New England Journal of Medicineu003c/iu003e, titled “Falling Insulin Prices – What Just Happened?” One: The market is awaiting the entry of certain manufacturers that “don’t benefit from high prices.” Two: Government regulations are making it “costlier” for insulin manufacturers to keep charging their prior prices. Three: Public shaming.u003c/pu003en

u003ch4u003eMedia Coverageu003c/h4u003e

u003culu003en tu003cliu003eu003ca href=u0022https://www.fiercepharma.com/pharma/impetus-behind-lilly-novo-and-sanofis-insulin-price-cuts-explained-reportu0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eFiercePharmau003c/au003eu003c/liu003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eWhat Spurred Lilly, Novo and Sanofi to Slash Insulin Prices? Expert Gives Her Takeu003c/divu003e

u003culu003en tu003cliu003eu003ca href=u0022https://www.nejm.org/doi/pdf/10.1056/NEJMp2303279u0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eNew England Journal of Medicineu003c/au003eu003c/liu003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eFalling Insulin Prices – What Just Happened?u003c/divu003e

ttu003csection class=u0022scrollspyu0022 id=u0022may-03u0022u003entttu003cp class=u0022monthsu0022u003eMay 3, 2023u003c/pu003enttu003c/sectionu003e

u003ch1u003eCivicaRx Disrupts Out of Control Prescription Medication Pricingu003c/h1u003enu003cp class=u0022body-contentu0022u003eCivica believes its model of rallying others to work together to ensure a reliable supply of fairly priced medicines is one that the wider pharmaceutical industry can ultimately support. u003c/pu003en

u003ch4u003eMedia Coverageu003c/h4u003e

u003culu003en tu003cliu003eu003ca href=u0022https://techbuzz.news/civicarx/u0022 target=u0022_blanku0022 rel=u0022noopener noreferreru0022u003eTechBuzzu003c/au003eu003c/liu003enu003c/ulu003enu003cdiv class=u0022timeline-media-titleu0022u003eCivicaRx Disrupts Out of Control Prescription Medication Pricing Through Market Solutions Rather Than Government Regulationu003c/divu003e

u003cstyleu003enn/* 1. Enable smooth scrolling */nhtml {ntscroll-behavior: smooth;n}nn/* 2. Make nav sticky nmain u003e nav {ntposition: sticky;nttop: 13rem;ntalign-self: start;n}n*/n/* 3. ScrollSpy active styles (see JS tab for activation) */n.section-nav li.active u003e a {ntcolor: red;ntfont-weight: 800;ntbackground-image: url(/wp-content/uploads/2020/08/red-arrow-right-01.png);nt background-size: 65px 20px;n background-position: 4px;n background-repeat: no-repeat;n}nn/* Sidebar Navigationn.section-nav {ntpadding-left: 0;nn}n */n.section-nav a {ntfont-size: 14px;nttext-decoration: none;ntdisplay: block;ntpadding: 0;ntcolor: #7c858c;nttext-align: center;nttransition: all 50ms ease-in-out; /* 💡 This small transition makes setting of the active state smooth */n}nn.section-nav a:hover,n.section-nav a:focus {ntcolor: #666;n}nn/** Poor man’s reset **/n* {ntbox-sizing: border-box;n}n/*nhtml, body {ntbackground: #fff;n}nnbody {ntfont-family: -apple-system, BlinkMacSystemFont, u0022Segoe UIu0022, u0022Robotou0022, u0022Oxygenu0022, u0022Ubuntuu0022, u0022Cantarellu0022, u0022Fira Sansu0022, u0022Droid Sansu0022, u0022Helvetica Neueu0022, sans-serif;n}n*/nul, ol {ntlist-style: none;ntmargin: 0;ntpadding: 0;n}nli {ntmargin-left: 1rem;n}nnh1 {ntfont-weight: 300;n}nt.site-footer .bottom-bar {nttdisplay: none!important;nt}nt.site-footer .widgets {n display: none;n}nt.footerlogo {nttdisplay: none!important;nttheight: 0px!important;nt}nu003c/styleu003ennu003c!u002du002du003cscriptu003ennt!function(t,e){u0022objectu0022==typeof exportsu0026u0026u0022objectu0022==typeof module?module.exports=e():u0022functionu0022==typeof defineu0026u0026define.amd?define([],e):u0022objectu0022==typeof exports?exports.scrollSpy=e():t.scrollSpy=e()}(window,(function(){return function(t){var e={};function o(n){if(e[n])return e[n].exports;var r=e[n]={i:n,l:!1,exports:{}};return t[n].call(r.exports,r,r.exports,o),r.l=!0,r.exports}return o.m=t,o.c=e,o.d=function(t,e,n){o.o(t,e)||Object.defineProperty(t,e,{enumerable:!0,get:n})},o.r=function(t){u0022undefinedu0022!=typeof Symbolu0026u0026Symbol.toStringTagu0026u0026Object.defineProperty(t,Symbol.toStringTag,{value:u0022Moduleu0022}),Object.defineProperty(t,u0022__esModuleu0022,{value:!0})},o.t=function(t,e){if(1u0026eu0026u0026(t=o(t)),8u0026e)return t;if(4u0026eu0026u0026u0022objectu0022==typeof tu0026u0026tu0026u0026t.__esModule)return t;var n=Object.create(null);if(o.r(n),Object.defineProperty(n,u0022defaultu0022,{enumerable:!0,value:t}),2u0026eu0026u0026u0022stringu0022!=typeof t)for(var r in t)o.d(n,r,function(e){return t[e]}.bind(null,r));return n},o.n=function(t){var e=tu0026u0026t.__esModule?function(){return t.default}:function(){return t};return o.d(e,u0022au0022,e),e},o.o=function(t,e){return Object.prototype.hasOwnProperty.call(t,e)},o.p=u0022u0022,o(o.s=0)}([function(t,e,o){t.exports=(t,e={})=u003e{const{ScrollSpy:n}=o(1),r=new n(t,e);return window.onload=r.onScroll(),window.addEventListener(u0022scrollu0022,()=u003er.onScroll()),r}},function(t,e,o){u0022use strictu0022;o.r(e),o.d(e,u0022ScrollSpyu0022,(function(){return n}));class n{constructor(t,e={}){if(!t)throw new Error(u0022First argument is query selector to your navigation.u0022);if(u0022objectu0022!=typeof e)throw new Error(u0022Second argument must be instance of Object.u0022);this.menuList=t instanceof HTMLElement?t:document.querySelector(t),this.options=Object.assign({},{sectionClass:u0022.scrollspyu0022,menuActiveTarget:u0022li u003e au0022,offset:0,hrefAttribute:u0022hrefu0022,activeClass:u0022activeu0022},e),this.sections=document.querySelectorAll(this.options.sectionClass)}onScroll(){const t=this.getSectionInView(),e=this.getMenuItemBySection(t);eu0026u0026(this.removeCurrentActive({ignore:e}),this.setActive(e))}getMenuItemBySection(t){if(!t)return;const e=t.getAttribute(u0022idu0022);return this.menuList.querySelector(`[${this.options.hrefAttribute}=u0022#${e}u0022]`)}getSectionInView(){for(let t=0;tu003cthis.sections.length;t++){const e=this.sections[t].offsetTop,o=e+this.sections[t].offsetHeight,n=(document.documentElement.scrollTop||document.body.scrollTop)+this.options.offset;if(nu003eeu0026u0026nu003c=o)return this.sections[t]}}setActive(t){t.classList.contains(this.options.activeClass)||t.classList.add(this.options.activeClass)}removeCurrentActive({ignore:t}){const{hrefAttribute:e,menuActiveTarget:o}=this.options,n=`${o}.active:not([${e}=u0022${t.getAttribute(e)}u0022])`;this.menuList.querySelectorAll(n).forEach(t=u003et.classList.remove(this.options.activeClass))}}}])}));ntnnnu003c/scriptu003enu003cscriptu003en window.onload = function () {n scrollSpy(‘#main-menu’, {n sectionClass: ‘.scrollspy’,n menuActiveTarget: ‘.menu-item’,n offset: -270n })ntn };ntntnu003c/scriptu003ennu003c!u002du002du003cscriptu003entntwindow.onload = function scrollWin() {n window.scrollTo(0, 300);n};nntnnu003c/scriptu003eu002du002du003en
Members
Governance
History
Civica Rx Entities RX
Civica, Inc.
CivicaScript
Civica Foundation
Generics
– For Hospitals
– For Retail
Biosimilars
– Insulin

Updates
Media
– Inquiries
– Assets

Opportunities
Culture

Membership
Partnership

Patients treated with Civica medications
10 Million